The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe.
Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the most important healthtech news every week!
Atomwise, which has developed a platform that makes predictions about potential medicines before they are made, raised the funding from Monsanto Growth Ventures, DCVC (Data Collective), and B Capital Group, with participation from others.
“3iOntario Digest presents a list of ongoing funding opportunities and other resources to accelerate health innovation. The newsletter is likely the best source of Healthtech grant opportunities available.”
– Daniel Warner, MediSeen founder and CEO
Holmes has been stripped of control of the blood-testing company she founded, is returning millions of shares to Theranos, and is barred from serving as an officer or director of a public company for 10 years, the SEC said in a statement Wednesday.
University of Calgary scientist Jeff Dunn says there has been no accepted way to get an image of a concussion, but he and his team have developed a device, called a Near-Infrared Spectroscopy, that measures communication in the brain by measuring oxygen levels in blood.
The company’s investors include Greater New York Hospital Association Ventures, Loeb Holding Corporation, former UnitedHealth Group executive Anthony Welters, former McKesson Extended Care president Fred Browne, and other unnamed investors.
The company’s new “smartwatch for all” also takes things a step further with the addition women’s health tracking, which adds menstrual cycle logging to the device’s healthcare tracking.
From microprocessor-controlled knees to computer-controlled socks, Aaron Holm, manager for consumer engagement, Ottobock Healthcare, discussed how technology is changing bionics and orthotics at SXSW.
Katie Fraser’s work in computational linguistics bridges artificial intelligence with health care. She and her startup colleagues at WinterLight Labs hope to improve Canadians’ lives with tools for the early detection of dementia.
Folks that subscribe to ClassPass Live will get access to a starter kit, unlimited live workouts, and a heart rate zone tracker.
Taha Kass-Hout will serve in a business development role focusing on health care projects.
Co-founder Connor Duffy says Reverie Labs’ ambition is to “become a full service molecule-as-a-service company.” It’s already partnered with several biotech companies and academic institutes working on treatments for diseases including influenza and cancer.
Subscribe to The Healthtech Times
Don’t forget to subscribe to The Healthtech Times using the form below to make sure it hits your email inbox every week!